Skip to main content
. 2013 Aug 12;98(10):3920–3925. doi: 10.1210/jc.2013-2411

Figure 3.

Figure 3.

Preabsorption of the patient serum and the commercial anti-PRL antibody using r-hPRL. This preabsorption abolished the signal from anti-PRL antibody (lower right panel) but did not affect the recognition by the patient serum (lower left panel), indicating that the autoantigen(s) recognized by the patient was not PRL itself.